We are live on ! Find out more

1,970 hedge funds and large institutions have $146B invested in Pfizer in 2015 Q4 according to their latest regulatory filings, with 195 funds opening new positions, 801 increasing their positions, 756 reducing their positions, and 80 closing their positions.

New
Increased
Maintained
Reduced
Closed

144% more first-time investments, than exits

New positions opened: 195 | Existing positions closed: 80

5% more funds holding

Funds holding: 1,8801,970 (+90)

1.41% more ownership

Funds ownership: 75.71%77.11% (+1.4%)

6% more repeat investments, than reductions

Existing positions increased: 801 | Existing positions reduced: 756

4% more capital invested

Capital invested by funds: $140B → $146B (+$6.18B)

5% less funds holding in top 10

Funds holding in top 10: 267253 (-14)

39% less call options, than puts

Call options by funds: $1.79B | Put options by funds: $2.95B

Holders
1,970
Holders Change
+90
Holders Change %
+4.79%
% of All Funds
51.67%
Holding in Top 10
253
Holding in Top 10 Change
-14
Holding in Top 10 Change %
-5.24%
% of All Funds
6.64%
New
195
Increased
801
Reduced
756
Closed
80
Calls
$1.79B
Puts
$2.95B
Net Calls
-$1.16B
Net Calls Change
-$1.83B
Name Holding Trade Value Shares
Change
Change in
Stake
NA
1676
NewEdge Advisors
Louisiana
$408K +$422K +13,412 New
SCM
1677
Stellar Capital Management
Arizona
$407K
SM
1678
Sciencast Management
New Jersey
$407K +$418K +13,280 New
NIA
1679
Northstar Investment Advisors
Colorado
$405K
RVPG
1680
Relative Value Partners Group
$404K
RWA
1681
River Wealth Advisors
Pennsylvania
$403K -$3.68K -117 -0.9%
PC
1682
Palo Capital
California
$403K +$42.6K +1,355 +11%
MJP
1683
Michael J. Puzo
$400K +$273K +8,685 +198%
LRPA
1684
L. Roy Papp & Associates
Arizona
$395K -$104K -3,310 -20%
Koshinski Asset Management
1685
Koshinski Asset Management
Illinois
$395K +$724 +23 +0.2%
NBC
1686
Neuberger Berman Canada
Ontario, Canada
$395K +$62.7K +1,994 +18%
JWM
1687
Jacobus Wealth Management
Wisconsin
$394K
MHS
1688
M Holdings Securities
Oregon
$393K -$59K -1,874 -13%
FC
1689
Fayerweather Charles
$393K +$404K +12,827 New
CG
1690
Corundum Group
Colorado
$389K +$45K +1,432 +12%
JIM
1691
Jensen Investment Management
Oregon
$388K -$39.8K -1,264 -9%
WA
1692
Wealth Architects
California
$388K -$283 -9 -0.1%
BWA
1693
Burt Wealth Advisors
Maryland
$388K +$12.6K +401 +3%
CW
1694
Cabot-Wellington
Massachusetts
$387K
EIM
1695
Emerson Investment Management
Massachusetts
$385K -$35.5K -1,127 -8%
ACA
1696
Anchor Capital Advisors
Massachusetts
$385K -$2.17K -69 -0.5%
CM
1697
Cornerstone Management
Georgia
$385K +$29.3K +932 +8%
HIM
1698
Hillsdale Investment Management
Ontario, Canada
$384K +$132K +4,210 +51%
AFP
1699
Ausdal Financial Partners
Iowa
$384K +$394K +12,527 New
MSTVIM
1700
Messner & Smith Theme Value Investment Management
California
$382K

PFE Hedge Fund Activity: Q4 2015 in Review

1,970 of the 3,813 institutional investors tracked by Wall St. Rank reported a position in Pfizer (PFE) for Q4 2015, worth a combined $146B — up 4.4% from $140B a quarter earlier.

Buyers outnumbered sellers: 195 funds opened new PFE positions and 80 closed out — a net gain of 115 holders — while 801 added to existing stakes and 756 trimmed.

The largest buyer was Deutsche Bank, adding an estimated $604M. The largest seller was Capital World Investors, cutting an estimated $1.47B.

  • 1,970 institutional investors held Pfizer (PFE) as of Q4 2015, up from 1,880 in Q3 2015.
  • Funds reported $146B of Pfizer stock for Q4 2015, up 4.4% quarter-over-quarter.
  • 195 funds opened new Pfizer positions in Q4 2015 and 80 closed out, a net change of +115 holders.
  • The largest Pfizer buyer in Q4 2015 was Deutsche Bank, an estimated $604M added.
  • The largest Pfizer seller in Q4 2015 was Capital World Investors, an estimated $1.47B sold.

Based on aggregated 13F filings for Q4 2015.